论文信息 - Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN - 字舞流文

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN

L. Chow | R. Hershberg | C. Morishima | M. Disis | C. Baik | K. Eaton | R. Martins | G. Dietsch | K. Manjarrez | J. K. Bryan | B. Goulart | L. Anderson